Michael Braun: The Work Is Not Finished in Sickle Cell Disease
Michael Braun, U.S. Specialty Care President at Pfizer, shared a post on LinkedIn:
“Sickle cell disease affects millions of people worldwide — and still carries the weight of inequity. For too many, the journey is defined not just by pain and crises, but by delayed diagnoses, limited access to specialized care, and treatment options that haven’t kept pace with the urgency.
On World Sickle Cell Day, I’m thinking about a community that has been asked to wait too long for progress — and what it means to truly show up for them.
For our team at Pfizer, that means continuing to advance our research and education in sickle cell disease, supporting scholarships, helping nonprofit organizations in their mission to ease the burden of travel to care, and listening closely to the people most affected.
Progress is possible, and it’s also necessary. Our work isn’t finished.
To everyone living with sickle cell, caring for someone who is, or fighting for change in this community:
Stay updated with Hemostasis Today.
-
Jun 20, 2026, 19:11Ayesha Masood: Delighted to Share My First Published Meta-Analysis
-
Jun 20, 2026, 18:56Registration Closing Tonight – 3rd Antithrombotic Stewardship Summit at ISTH 2026 – Anticoagulation Forum
-
Jun 20, 2026, 13:06Bastian Volbers: ESO and SESAM Sign Landmark Affiliation Agreement at SESAM 2026
-
Jun 20, 2026, 12:56Yusra Junaid: Two New Publications in Thrombosis and Cancer Research
-
Jun 20, 2026, 12:39Mayka Sanchez: Updates from EFAPH 2026 Meeting
-
Jun 20, 2026, 12:22Karen Fahey: A More Inclusive Future for the Bleeding Disorders Community
-
Jun 20, 2026, 10:48Alliah Czarielle Formalejo: Loving People Without Defining Them
-
Jun 20, 2026, 10:18Luciano Martelotto: CD200R1, IL-17A, and the Future of Cancer Thrombosis Prevention
-
Jun 20, 2026, 10:09Nicolle Davis: Celebrating the Team Behind Life-Saving Mobile Stroke Care